In spite of the gains at the opening, major US indices trade in the red, moderating yesterday’s hikes inspired by the lack of pro-inflationary surprises in the CPI report. Nasdaq dipped the most (-0.4%), followers by DJIA (-0.2%), S&P500 (-0.1%) and Russell 2000 (-0.07%).
US jobless claims came in slightly higher than expected (217K vs est. 210K), rebounding for the first time since mid-December. Retail sales in December, on the other hand, fell 0.2% percentage point short of analysts' estimates (0.4% MoM vs est. 0.6%).
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Source: Volatility currently observed on Wall Street. Source: xStation5
US100 (D1)
Contracts for Nasdaq 100 index are trading flat after bullishly returning above 21400 from its local low yesterday. Although mixed performance of Magnificent 7 stocks prevents the tech heavy composite from a decisive comeback, the promising AI demand forecasts declared today by TSM might help fostering regained enthusiasm on Wall Street.
Source: xStation5
Corporate news:
- Bank of America (BAC.US) trades 0.9% down despite beating the estimates with its latest earnings report. BofA’s strong performance last quarter was mainly driven by an increased net interest income and investment-banking fees.
- Revenue: $25.35b (vs est. $25.16b)
- EPS: $0.82 (vs est. $0.77)
- Net interest income: $14.36b (vs est. $14.12b)
- Investment banking revenue: $1.65b (vs est. $1.47b)
- Meta (META.US) loses 0.7% following a report stating that Donald Trump considers delaying the TikTok ban by 60-90 days. Speculations about ByteDance selling TikTok to Elon Musk add more ambiguity about the future shape of the social media market, with hopes of user migration to Meta platforms diminishing significantly.
- Morgan Staneley (MS.US) adds 2% thanks to the estimate beat for Q4, as reported in today’s earrings report. The company exceeded the analysts forecasts in all key categories, with the equities and trading revenue turning 25% higher than previously expected.
- Rev. $16.2b (vs est. $16.06b)
- EPS $2.22 (vs est. $1.69)
- Equities sales & trading rev $3.33B (vs est. $2.63B)
- Net interest income $2.55B (vs est. $2B)
- Taiwan Semiconductor Manufacturing (TSM.US) shares hike 5.4% on the latest sales projections. The guidance encompasses revenue estimates of $25-$25.8 bn (6% higher than expected) and increased spending of $38-$42 bn (+19%) on technology due to higher AI hardware demand.
- United Health (UNH.US) shares are down 4.5% due to the weaker-than expected financials for Q4 2024, hindered primarily by high medical costs and poor performance of the insurance division.
- Adj EPS $6.81 (vs est. $6.71)
- Rev. $100.81b (vs est. $101.68b)
- Insurance revenue: $74.1b (vs est. $75.2b)
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
